Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for CTKB

Stock NameCytek Biosciences Inc
TickerCTKB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS23285D1090
LEI549300K2J28BOC6FBO89

Show aggregate CTKB holdings

News associated with CTKB

15,716 Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB) Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC bought a new stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 15,716 shares of the company’s stock, valued at approximately $63,000. Several other hedge funds have also recently added […] - 2025-07-11 04:14:50
Diversified Trust Co Acquires Shares of 24,532 Cytek Biosciences, Inc. (NASDAQ:CTKB)
Diversified Trust Co bought a new stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) in the 1st quarter, HoldingsChannel.com reports. The firm bought 24,532 shares of the company’s stock, valued at approximately $98,000. Several other institutional investors and hedge funds also recently made changes to their positions in CTKB. Millennium Management LLC […] - 2025-07-03 05:10:56
Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.4% – Time to Buy?
Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Free Report) were up 2.4% on Tuesday . The stock traded as high as $3.60 and last traded at $3.48. Approximately 1,129,459 shares traded hands during mid-day trading, an increase of 38% from the average daily volume of 819,132 shares. The stock had previously closed at $3.40. […] - 2025-07-02 02:46:59
Quantinno Capital Management LP Purchases New Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB)
Quantinno Capital Management LP bought a new stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 14,220 shares of the company’s stock, valued at approximately $92,000. Several other institutional investors have also modified […] - 2025-05-29 06:22:53
Millennium Management LLC Has $5.22 Million Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)
Millennium Management LLC increased its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 321.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 803,923 shares of the company’s stock after acquiring an additional 613,314 shares during the quarter. Millennium Management […] - 2025-05-29 05:20:53
Morgan Stanley Has Lowered Expectations for Cytek Biosciences (NASDAQ:CTKB) Stock Price
Cytek Biosciences (NASDAQ:CTKB – Free Report) had its price objective reduced by Morgan Stanley from $9.00 to $7.00 in a report issued on Wednesday morning,Benzinga reports. They currently have an equal weight rating on the stock. Other equities research analysts have also recently issued research reports about the stock. TD Cowen cut shares of Cytek […] - 2025-05-29 03:00:47
Price T Rowe Associates Inc. MD Purchases 7,686 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Price T Rowe Associates Inc. MD lifted its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 19.5% in the 4th quarter, HoldingsChannel reports. The fund owned 47,189 shares of the company’s stock after purchasing an additional 7,686 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Cytek Biosciences […] - 2025-05-16 04:31:02
The Goldman Sachs Group Issues Pessimistic Forecast for Cytek Biosciences (NASDAQ:CTKB) Stock Price
Cytek Biosciences (NASDAQ:CTKB – Get Free Report) had its price objective reduced by equities researchers at The Goldman Sachs Group from $3.50 to $3.00 in a research report issued on Monday,Benzinga reports. The firm currently has a “sell” rating on the stock. The Goldman Sachs Group’s price target would suggest a potential upside of 0.67% […] - 2025-05-14 04:48:57
Voya Investment Management LLC Sells 3,547 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Voya Investment Management LLC cut its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 8.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,749 shares of the company’s stock after selling 3,547 shares during the […] - 2025-05-13 05:54:58
Cytek Biosciences (NASDAQ:CTKB) Cut to “Hold” at TD Cowen
TD Cowen cut shares of Cytek Biosciences (NASDAQ:CTKB – Free Report) from a buy rating to a hold rating in a report issued on Friday morning, MarketBeat reports. They currently have $4.00 price objective on the stock. CTKB has been the subject of a number of other research reports. Piper Sandler lowered their target price […] - 2025-05-12 04:38:52
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by Legal & General Group Plc
Legal & General Group Plc increased its position in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 3.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 313,037 shares of the company’s stock after acquiring an additional 11,346 shares during the period. Legal […] - 2025-04-25 05:16:53
Renaissance Technologies LLC Purchases 251,000 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Renaissance Technologies LLC grew its holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 118.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 462,600 shares of the company’s stock after purchasing an additional 251,000 shares during the quarter. Renaissance Technologies LLC owned about […] - 2025-04-24 04:50:56
Analysts Anticipate SPTM Will Reach $81
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-22 08:05:47
ExodusPoint Capital Management LP Has $503,000 Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB)
ExodusPoint Capital Management LP reduced its stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 35.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 77,536 shares of the company’s stock after selling 41,706 shares during the quarter. ExodusPoint […] - 2025-04-13 05:29:02
Wellington Management Group LLP Has $9.85 Million Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB)
Wellington Management Group LLP decreased its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 24.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,517,214 shares of the company’s stock after selling 489,925 shares during the […] - 2025-04-10 06:23:16
American Century Companies Inc. Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB)
American Century Companies Inc. boosted its holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 10.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 204,745 shares of the company’s stock after buying an additional 19,802 shares during the period. American Century Companies Inc.’s holdings in Cytek […] - 2025-04-10 05:00:50
KLP Kapitalforvaltning AS Purchases Shares of 20,200 Cytek Biosciences, Inc. (NASDAQ:CTKB)
KLP Kapitalforvaltning AS acquired a new position in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 20,200 shares of the company’s stock, valued at approximately $131,000. A number of other large investors have also […] - 2025-04-10 04:20:51
Prudential Financial Inc. Purchases 63,600 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Prudential Financial Inc. raised its position in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 57.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 173,382 shares of the company’s stock after acquiring an additional 63,600 shares during the period. […] - 2025-04-07 04:42:53
Cibc World Markets Corp Buys Shares of 11,358 Cytek Biosciences, Inc. (NASDAQ:CTKB)
Cibc World Markets Corp purchased a new position in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 11,358 shares of the company’s stock, valued at approximately $74,000. Several other large investors also recently made […] - 2025-03-28 06:16:54
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by Intech Investment Management LLC
Intech Investment Management LLC boosted its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 114.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 49,704 shares of the company’s stock after buying an additional 26,567 shares during the quarter. Intech Investment […] - 2025-03-26 07:16:50
Cytek Biosciences (NASDAQ:CTKB) Earns “Overweight” Rating from Stephens
Cytek Biosciences (NASDAQ:CTKB – Get Free Report)‘s stock had its “overweight” rating restated by Stephens in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $6.00 price objective on the stock. Stephens’ target price points to a potential upside of 47.78% from the company’s current price. CTKB has been […] - 2025-03-21 04:42:53
Piper Sandler Issues Pessimistic Forecast for Cytek Biosciences (NASDAQ:CTKB) Stock Price
Cytek Biosciences (NASDAQ:CTKB – Get Free Report) had its price objective cut by research analysts at Piper Sandler from $8.50 to $8.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Piper Sandler’s price objective would indicate a potential upside of 78.97% from the stock’s current price. […] - 2025-03-06 05:27:22
Cytek Biosciences, Inc. (NASDAQ:CTKB) Stake Boosted by Principal Financial Group Inc.
Principal Financial Group Inc. increased its position in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 0.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 506,925 shares of the company’s stock after purchasing an additional 3,753 shares during the period. Principal Financial Group Inc.’s holdings in Cytek Biosciences were worth $3,290,000 as […] - 2025-03-05 07:04:59

iShares Healthcare Innovation UCITS ETF USD (Acc) CTKB holdings

DateNumber of CTKB Shares HeldBase Market Value of CTKB SharesLocal Market Value of CTKB SharesChange in CTKB Shares HeldChange in CTKB Base ValueCurrent Price per CTKB Share HeldPrevious Price per CTKB Share Held
2025-11-12 (Wednesday)161,484USD 776,738CTKB holding increased by 3230USD 776,7380USD 3,230 USD 4.81 USD 4.79
2025-11-11 (Tuesday)161,484USD 773,508CTKB holding increased by 6459USD 773,5080USD 6,459 USD 4.79 USD 4.75
2025-11-10 (Monday)161,484USD 767,049CTKB holding increased by 20993USD 767,0490USD 20,993 USD 4.75 USD 4.62
2025-11-07 (Friday)161,484USD 746,056CTKB holding increased by 12919USD 746,0560USD 12,919 USD 4.62 USD 4.54
2025-11-06 (Thursday)161,484USD 733,137CTKB holding increased by 85586USD 733,1370USD 85,586 USD 4.54 USD 4.01
2025-11-05 (Wednesday)161,484USD 647,551CTKB holding increased by 16149USD 647,5510USD 16,149 USD 4.01 USD 3.91
2025-11-04 (Tuesday)161,484USD 631,402CTKB holding decreased by -4845USD 631,4020USD -4,845 USD 3.91 USD 3.94
2025-11-03 (Monday)161,484USD 636,247CTKB holding increased by 6459USD 636,2470USD 6,459 USD 3.94 USD 3.9
2025-10-31 (Friday)161,484USD 629,788CTKB holding increased by 12919USD 629,7880USD 12,919 USD 3.9 USD 3.82
2025-10-30 (Thursday)161,484USD 616,869CTKB holding decreased by -30682USD 616,8690USD -30,682 USD 3.82 USD 4.01
2025-10-29 (Wednesday)161,484USD 647,551CTKB holding decreased by -30682USD 647,5510USD -30,682 USD 4.01 USD 4.2
2025-10-28 (Tuesday)161,484USD 678,233CTKB holding increased by 8074USD 678,2330USD 8,074 USD 4.2 USD 4.15
2025-10-27 (Monday)161,484USD 670,159CTKB holding decreased by -17763USD 670,1590USD -17,763 USD 4.15 USD 4.26
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CTKB by Blackrock for IE00BYZK4776

Show aggregate share trades of CTKB

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-24SELL-1,3884.2604.285 4.282USD -5,944 4.33 Profit of 71 on sale
2025-09-11BUY7024.1304.140 4.139USD 2,906 4.39
2025-07-08SELL-6933.4303.475 3.470USD -2,405 4.47 Profit of 693 on sale
2025-06-24SELL-7173.2303.275 3.271USD -2,345 4.53 Profit of 905 on sale
2025-06-23SELL-7173.1203.140 3.138USD -2,250 4.54 Profit of 1,007 on sale
2025-06-11SELL-7033.4403.570 3.557USD -2,501 4.63 Profit of 751 on sale
2025-05-30SELL-7112.7702.820 2.815USD -2,001 4.72 Profit of 1,353 on sale
2025-05-21BUY7092.4802.651 2.634USD 1,867 4.85
2025-05-14SELL-4,2182.7302.950 2.928USD -12,350 4.93 Profit of 8,453 on sale
2025-04-30SELL-6973.7103.750 3.746USD -2,611 5.07 Profit of 924 on sale
2025-04-28SELL-6983.8603.870 3.869USD -2,701 5.10 Profit of 857 on sale
2025-04-25SELL-6963.7703.860 3.851USD -2,680 5.11 Profit of 877 on sale
2025-04-11SELL-4,2963.7103.720 3.719USD -15,977 5.23 Profit of 6,510 on sale
2025-04-08SELL-2,1213.3703.800 3.757USD -7,969 5.29 Profit of 3,257 on sale
2025-04-07SELL-1,5103.6703.940 3.913USD -5,909 5.31 Profit of 2,112 on sale
2025-03-31SELL-1,4104.0104.065 4.060USD -5,724 5.38 Profit of 1,862 on sale
2025-03-21SELL-1,3984.2004.295 4.286USD -5,991 5.48 Profit of 1,670 on sale
2025-03-12SELL-7154.1704.290 4.278USD -3,059 5.61 Profit of 952 on sale
2025-02-28SELL-7134.4904.640 4.625USD -3,298 5.77 Profit of 815 on sale
2025-02-25BUY7135.1305.280 5.265USD 3,754 5.81
2025-02-20SELL-7135.2005.365 5.348USD -3,813 5.84 Profit of 353 on sale
2025-02-19BUY1,4225.3605.405 5.401USD 7,680 5.85
2025-02-18BUY7115.3105.420 5.409USD 3,846 5.86
2024-12-30SELL-1,3486.5506.828 6.800USD -9,167 6.04 Loss of -1,024 on sale
2024-12-06SELL-6876.4706.850 6.812USD -4,680 5.98 Loss of -573 on sale
2024-12-04SELL-6876.6906.805 6.793USD -4,667 5.93 Loss of -591 on sale
2024-12-03SELL-1,3786.7056.900 6.881USD -9,481 5.90 Loss of -1,345 on sale
2024-11-21SELL-7056.4606.540 6.532USD -4,605 5.62 Loss of -640 on sale
2024-11-20SELL-6826.1306.300 6.283USD -4,285 5.60 Loss of -469 on sale
2024-11-19BUY12,9686.1306.140 6.139USD 79,611 5.56
2024-11-18SELL-2,5846.0306.100 6.093USD -15,744 5.54 Loss of -1,441 on sale
2024-11-12SELL-6447.0407.230 7.211USD -4,644 5.44 Loss of -1,144 on sale
2024-11-07SELL-6467.2207.630 7.589USD -4,902 5.17 Loss of -1,560 on sale
2024-11-05SELL-1,2925.4405.540 5.530USD -7,145 4.95 Loss of -753 on sale
2024-10-28SELL-6484.8904.940 4.935USD -3,198 4.91 Loss of -15 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CTKB

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19132,3730251,12552.7%
2025-09-18142,2170265,46553.6%
2025-09-17152,9050342,35944.7%
2025-09-16127,0540243,64252.1%
2025-09-15140,8710314,41444.8%
2025-09-12195,9290437,28044.8%
2025-09-11150,2430292,93651.3%
2025-09-10136,0480310,48743.8%
2025-09-09123,923400287,74143.1%
2025-09-08117,8261,000293,59340.1%
2025-09-0596,5060218,17644.2%
2025-09-0466,5020209,42231.8%
2025-09-03214,8040384,14955.9%
2025-09-02148,0441351,75642.1%
2025-08-29148,2230319,37746.4%
2025-08-28174,0170454,80338.3%
2025-08-27103,9170231,62144.9%
2025-08-26191,7610363,86852.7%
2025-08-25141,3461198,11271.3%
2025-08-22129,0760229,67956.2%
2025-08-21120,840560195,20461.9%
2025-08-2069,0160144,85247.6%
2025-08-1999,9717,721162,42661.5%
2025-08-1878,4902142,87154.9%
2025-08-15108,4552215,91050.2%
2025-08-14227,289500363,08562.6%
2025-08-13136,133890492,73227.6%
2025-08-12196,6790468,10742.0%
2025-08-11320,8000570,57456.2%
2025-08-08293,4200431,63568.0%
2025-08-07256,60112,953430,24059.6%
2025-08-06340,7590516,72465.9%
2025-08-05197,8420452,22643.7%
2025-08-04222,8320496,23144.9%
2025-08-01302,2660591,54251.1%
2025-07-31186,4070443,49642.0%
2025-07-30281,4842561,15350.2%
2025-07-29146,3150286,13151.1%
2025-07-28185,5980431,33143.0%
2025-07-25392,5863,900602,26065.2%
2025-07-24104,0470185,05756.2%
2025-07-23119,8272,300227,58852.7%
2025-07-2280,4455,658187,16943.0%
2025-07-2153,928195,81556.3%
2025-07-18116,0190196,22659.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.